1, lei 25, 1, lei 25, 1, lei 18, 1, lei 27, /, lei 11, 45, 22, 3, Total , 1,, , , , , , 1, lei | 1, lei | 1, lei | 1, lei | 1, lei 1, lei Total value 41, 25, 25 . / Type: Journal Article DOI: /s The Digital Object Identifier (DOI) System enables identification of digital entities.
|Published (Last):||13 May 2013|
|PDF File Size:||5.40 Mb|
|ePub File Size:||4.68 Mb|
|Price:||Free* [*Free Regsitration Required]|
Primary cerebral malignant melanoma: Analysis of diacylglycerols by ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry: National Center for Biotechnology InformationU. The lowest serum dilution able to inhibit virus hemagglutination is shown. Phenotypic characteristics and genotypic correlation between Salmonella isolates from a slaughterhouse and retail markets in Yangzhou, China.
Microneedle delivery of an M2e-TLR5 ligand fusion eli to skin confers broadly cross-protective influenza immunity.
Blue arrows indicate the location of flexible linkers. Design and synthesis of potent HIV-1 protease inhibitors with S -tetrahydrofuran-tertiary amine-acetamide as P2-ligand: Bleeding, infection, and sampling were performed under light anesthesia via inhalation of isoflurane to reduce mouse suffering.
Natural variation in 1684 enhances rice adaptation to cold habitats. Here we report methodology to generate double-layered protein nanoparticles as a universal influenza vaccine.
Champion2 and Bao-Zhong Wang 1.
Legal Entity Identifier – LEI Database Search
Twenty-four hours after liposome administration, mice were injected i. See-through near-eye displays enabling vision correction.
Inhibition of gal-3 expression decreased S-phase but increased G1 phase cells. The Journal of Physiology.
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
Open Forum Infectious Diseases. Fatigue analysis of tympanic membrane after ossiculoplasty. The P values were generated by analyzing data with a two-tail unpaired t test using the Prism 5 program GraphPad software.
A novel biliary stent 1168 with silver nanoparticles prolongs the unobstructed period and survival via anti-bacterial activity.
Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza. Neutralization assay The neutralization assay was described previously An Institute of Physics Journal.
Design of 4MtG recombinant protein Tetrameric tandem M2e polypeptides 4 copies were stabilized by introducing a foreign tetramerization motif tetra- GCN4 at the C-terminal of the recombinant 4MtG protein, as diagrammed in Fig. Recombinant hrH1 and hrH3 were purified from rBV-based insect cell protein expression as done for the 4MtG purification. A promising approach is to express a standalone HA stalk domain without the highly immunogenic and strain-specific head domain, and a stabilized M2e with high epitope density.
Influenza virus-like particles containing M2 induce broadly cross protective immunity. A common solution to group 2 influenza virus neutralization.
Environmental Pollution Barking, Essex: However, the immunomodulatory effects of PNp have been shown to be a function of many aspects, including size 4748shape 4950charge 51surface chemistry 52 and administration route 32 Fifty microliter DPBS was used as a placebo. Blue light-promoted cross-coupling of aryldiazoacetates and diazocarbonyl compounds.
Cellular Physiology and Biochemistry: Impagliazzo A, et al. Advances in the development of influenza virus vaccines. Deng L, et al. In this study, we found that layered PNps composed of structure-stabilized HA stalk domains from both HA groups, and novel constructed M2e, are highly immunogenic to induce immune protection against homosubtypic and heterosubtypic influenza A virus challenges.
The generation of hrHA representatives from both phylogenetic groups is essential to formulate a vaccine that can elicit a genuinely universal protective response. Dashed lines indicate the sequences replaced with linkers shown below. A label-free colorimetric biosensor for sensitive detection of vascular endothelial growth factor